Skip to main content

Table 1 Clinicopathological characteristics of patients with ultrasound and MRI

From: Prediction of high nodal burden with ultrasound and magnetic resonance imaging in clinically node-negative breast cancer patients

Characteristics

Patients with ultrasound

(n = 312)

Patients with MRI

(n = 256)

P value

Age

  

.926

  ≤ 50 years

156 (50.0%)

129 (50.4%)

 

  > 50 years

156 (50.0%)

127 (49.6%)

 

Histologic type

 Invasive ductal

288 (92.3%)

236 (92.2%)

.945

 Invasive lobular

12 (3.8%)

11 (4.3%)

 

 Othersa

12 (3.8%)

9 (3.5%)

 

Pathological T stage

  

.945

 T1

236 (75.6%)

195 (76.2%)

 

  ≥ T2

76 (24.4%)

61 (23.8%)

 

Tumor focality

  

.970

 Unifocal

247 (79.2%)

203 (79.3%)

 

 Multifocal/multicentric

65 (20.8%)

53 (20.7%)

 

Tumor location

  

.859

 Upper outer

150 (48.1%)

125 (48.8%)

 

 Othersb

162 (51.9%)

131 (51.2%)

 

Histologic grade

  

.636

 Low

33 (10.6%)

24 (9.4%)

 

 Moderate or High

279 (89.4%)

232 (90.6%)

 

HR status

  

.720

 Negative

62 (19.9%)

54 (21.1%)

 

 Positive

250 (80.1%)

202 (78.9%)

 

HER2 statusc

  

.591

 Negative

232 (80.6%)

188 (78.7%)

 

 Positive

56 (19.4%)

51 (21.3%)

 

Type of axillary surgery

  

.903

 SLNB

59 (18.9%)

45 (17.6%)

 

 AS

224 (71.8%)

188 (73.4%)

 

 ALND

29 (9.3%)

23 (9.0%)

 
  1. HR hormone receptor, HER2 human epidermal growth factor receptor 2, SLNB sentinel lymph node biopsy, AS axillary sampling, ALND axillary lymph node dissection
  2. aOthers include mucinous cancer (n = 10) and metaplastic cancer (n = 2)
  3. bOther include upper inner, lower inner, lower outer, and subareolar
  4. cHER2 status was only available in 288 patients with ultrasound and 239 patients with MRI